Hivandhepatitis.com – aasld 2016: liver cancer risk reduced after hepatitis c treatment, but vigilance needed
Contents FDA Says Hepatitis C Drug Users Risk Reactivation Those who are cured of hepatitis C following a span of direct-acting antiviral treatment don’t have a greater chance of developing hepatocellular carcinoma (HCC) — and most likely possess a reduced risk — based on studies from Italia and Canada presented at American Association for study …